Showing results (71-80 of 121) with videos related to

Sort By:
Pageof 13
Wellcome Open Research|August 15, 2022
OpenSAFELY: Representativeness of electronic health record platform OpenSAFELY-TPP data compared to the population of EnglandColm Andrews, Anna Schultze, Helen Curtis, et al.
Trials|October 3, 2024
Utilising primary care electronic health records to deliver the ALABAMA randomised controlled trial of penicillin allergy assessmentShadia Ahmed, Joanne Fielding, Catherine E Porter, et al.
BMJ Open|February 22, 2023
Protocol for an OpenSAFELY cohort study collecting patient-reported outcome measures using the TPP Airmid smartphone application and linked big data to quantify the health and economic costs of long COVID (OpenPROMPT)Emily Herrett, Keith Tomlin, Liang-Yu Lin, et al.
Eclinicalmedicine|May 27, 2024
Clinical coding of long COVID in primary care 2020-2023 in a cohort of 19 million adults: an OpenSAFELY analysisAlasdair D Henderson, Ben Fc Butler-Cole, John Tazare, et al.
Wellcome Open Research|June 22, 2023
First dose COVID-19 vaccine coverage amongst adolescents and children in England: an analysis of 3.21 million patients' primary care records in situ using OpenSAFELYLisa E Hopcroft, Helen J Curtis, Andrew D Brown, et al.
The Lancet Regional Health. Europe|May 1, 2024
Impact of long COVID on health-related quality-of-life: an OpenSAFELY population cohort study using patient-reported outcome measures (OpenPROMPT)Oliver Carlile, Andrew Briggs, Alasdair D Henderson, et al.
Epidemiology (Cambridge, Mass.)|September 23, 2025
OpenSAFELY: Effectiveness of COVID-19 Vaccination in Children and AdolescentsColm D Andrews, Edward P K Parker, Elsie Horne, et al.
The Lancet Regional Health. Europe|November 6, 2023
Comparative effectiveness of nirmatrelvir/ritonavir versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised high-risk patients during Omicron waves: observational cohort study using the OpenSAFELY platformBang Zheng, John Tazare, Linda Nab, et al.
BMJ Mental Health|September 15, 2023
Impact of the COVID-19 pandemic on antipsychotic prescribing in individuals with autism, dementia, learning disability, serious mental illness or living in a care home: a federated analysis of 59 million patients' primary care records in situ using OpenSAFELYOrla Macdonald, Amelia Green, Alex Walker, et al.
British Journal of Clinical Pharmacology|April 8, 2024
OpenSAFELY: The impact of COVID-19 on azathioprine, leflunomide and methotrexate monitoring, and factors associated with change in monitoring rateAndrew D Brown, Louis Fisher, Helen J Curtis, et al.
Pageof 13